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The 2016 American Association for Thoracic Surgery (AATS) guidelines for surgical treatment of infective
endocarditis (IE) are question based and address questions of specific relevance to cardiac surgeons. Clinical
scenarios in IE are often complex, requiring prompt diagnosis, early institution of antibiotics, and decisionmaking related to complications, including risk of embolism and timing of surgery when indicated. The
importance of an early, multispecialty team approach to patients with IE is emphasized. Management issues
are divided into groups of questions related to indications for and timing of surgery, pre-surgical work-up,
preoperative antibiotic treatment, surgical risk assessment, intraoperative management, surgical management,
surveillance, and follow up. Standard indications for surgery are severe heart failure, severe valve dysfunction,
prosthetic valve infection, invasion beyond the valve leaflets, recurrent systemic embolization, large mobile
vegetations, or persistent sepsis despite adequate antibiotic therapy for more than 5–7 days. The guidelines
emphasize that once an indication for surgery is established, the operation should be performed as soon as
possible. Timing of surgery in patients with strokes and neurologic deficits require close collaboration with
neurological services. In surgery infected and necrotic tissue and foreign material is radically debrided and
removed. Valve repair is performed whenever possible, particularly for the mitral and tricuspid valves. When
simple valve replacement is required, choice of valve—mechanical or tissue prosthesis—should be based
on normal criteria for valve replacement. For patients with invasive disease and destruction, reconstruction
should depend on the involved valve, severity of destruction, and available options for cardiac reconstruction.
For the aortic valve, use of allograft is still favored.
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Introduction
Infective endocarditis (IE) is the most severe and potentially
devastating complication of heart valve disease, be it native
valve endocarditis (NVE), prosthetic valve endocarditis
(PVE), or infection on another cardiac device (1-6). An
increasingly elderly population with degenerative heart
valve disease and an increase in staphylococcal infections
have contributed to an increase in the prevalence of IE in
the last 30 years. An increasing number of patients undergo
heart surgery or receive prosthetic valves, pacemakers, and
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defibrillators, all factors associated with increased risk of IE.
Without treatment, IE is almost uniformly fatal. Even
at experienced centers, operations for IE remain associated
with the highest mortality of any valve disease (1-12).
Multicenter studies still report in-hospital mortality of
15–20% and 1-year mortality approaching 40% (1-13).
Caring for patients with IE requires a team of physicians
with expertise in various aspects of the disease. The
American Association for Thoracic Surgery (AATS)
guidelines address questions relevant and important to
cardiac surgeons before, during, and after operation: when
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to operate, how to prepare the patient for operation, how
to operate, and other issues relevant to management and
follow up of patients after surgery (1-6). The focus of the
2016 guidelines is active and suspected IE affecting valves
and intracardiac structures and management of concomitant
device infections. Management of isolated infections of
devices, including pacemakers, defibrillators, ventricular
assist devices, and others is not addressed.
Because the clinical scenarios presented by patients
with IE are most often complex (14,15), their successful
management requires a multispecialty team approach.
As the role of surgery and early surgery is expanded, the
surgeon should be part of the management team from the
beginning. This has also been emphasized in the most recent
2015 ACC/AHA guidelines, and the European Society
of Cardiology (ESC) guidelines, which recommend that
patients with IE should be managed at reference centers by
a specialized “endocarditis team” (2,3). The format of AATS
consensus guidelines allows the breakdown of complex
management questions related to IE into relevant clinical
questions. In the following sections, we will review the 2016
AATS consensus guidelines for surgical treatment of IE.
Both authors of this review were members of the writing
committee for the 2016 AATS endocarditis guidelines (1).
Pathophysiology and microbiology of IE
The key to understanding IE is appreciating the pathologic
progression (16). Circulating organisms, bacteria or other,
adhere to damaged areas of the endocardium, (valves,
ventricular septal defects), endothelium (patent ductus),
or foreign material exposed in the bloodstream (prosthetic
heart valves, pacemaker leads). Such damaged areas are
sites for development of vegetations. Vegetations are the
main source of embolization. The organisms produce
and release enzymes that disintegrate tissue, primarily
valve cusps and leaflets, resulting in leaky valves. When
tissue integration involves the valve annulus, the infection
invades the extravascular areas; “invasive disease”. Causative
microorganism/pathogen, position (aortic, mitral, or rightsided), and type of infected valve (native or prosthetic)
are important for pathology and prognosis (10,11,16).
Bacteria and fungi have a species-specific repertoire of
virulence factors that allow them to establish and maintain
IE. Staphylococci and streptococci are the most common,
aggressive, and destructive bacteria. Severity of invasion and
destruction seems to be a function of virulence and time,
with S aureus being most aggressive and destructive.
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Emboli from vegetations cause stroke, mycotic
aneurysms, and related phenomena. Toxins and enzymes
cause tissue disintegration and invasion resulting in valve
regurgitation, fistulas, paravalvular abscesses, and heart
block. Valves made regurgitant by bacterial destruction
will continue to leak even if the infection is ultimately
eradicated. Disease stage at diagnosis is related to pathogen
virulence and disease duration.
Systemic emboli are common in patients with leftsided IE. Embolic strokes, with or without hemorrhagic
conversion, are frequent and clinically important (2-4).
Although less common, systemic septic emboli can cause
mycotic aneurysms in any artery, including the aorta. Rightsided IE frequently showers the lungs with septic emboli,
leading to pulmonary abscesses and empyema. Right-sided
IE can also be responsible for systemic emboli in patients
with patent foramen ovale.
The microbiology of IE varies depending on whether
the valve is native or prosthetic, and whether the
infection is community acquired or healthcare associated.
Staphylococci, streptococci, and enterococci are responsible
for approximately 85% of all IE, with staphylococci and
streptococci being the most common aggressive and
destructive bacteria causing IE. Fungi form vegetations or
balls, but are usually less invasive, although they can lead
to development of mycotic aneurysms and easily become
disseminated.
All patients diagnosed with IE are first treated with
antimicrobials, initially broad spectrum, and then adjusted
to the sensitivity pattern once it is known. Antimicrobials to
which the organisms are sensitive clear the bacteremia, may
or may not prevent or halt further destruction, and may, if
initiated early enough cure the infection (2-4,6). Cure of
the infection will not restore integrity of damaged valves or
repair invasive disease. Taking advantage of the operative
specimens for cultures and sequencing of operative
specimens can help identify the causative microorganism.
The hypothesis that IE is a biofilm-associated infection
offers plausible explanations as to why IE related infections
are difficult to treat, why recurrence may occur after
seemingly successful medical treatment, and why surgery is
often required. Biofilm-producing bacterial populations live
embedded in a self-produced extracellular polysaccharide
slime-like matrix protecting them from the host’s immune
defenses and impedes antimicrobial efficacy (17). Capacity
for biofilm production is a hallmark of microorganisms that
commonly cause IE, including staphylococci, streptococci,
and enterococci. Surgery not only removes infected

Ann Cardiothorac Surg 2019;8(6):630-644 | http://dx.doi.org/10.21037/acs.2019.10.05

Pettersson and Hussain. AATS infective endocarditis guidelines

632
Recommendations

COR

LOE

Patients with suspected IE should ideally be cared for at centers with access to a complete team, including cardiology,
infectious disease, cardiac surgery, and other services needed to handle IE complications

I

B

Surgeons operating on patients with IE should be well-trained, experienced valve surgeons who are well versed in the
different reconstruction techniques needed by patients with advanced disease

I

C

At the time of surgery the patient should be on an effective antimicrobial regimen (correct dosage and route of administration)
to which the causative microorganism is sensitive, or be broadly covered when organism and sensitivity are unknown

I

B

For surgery planning, the surgeon should have the best possible understanding of the pathology. This will usually require
advanced imaging techniques, such as TEE

I

B

IIb

C

1. Who should care for and operate on patients with IE?

2. Diagnosis of IE: What does the surgeon need to know?

Use of imaging modalities other than echocardiography may also be appropriate in selected cases

Figure 1 Team approach to patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST, et al. 2016 American Association for
Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac Cardiovasc Surg 2017;153:12411258.e29, with permission from Elsevier.

tissue and foreign material, but also mechanically disrupts
the biofilm and exposes residual live microorganisms to
antimicrobials, antibodies, and immune cells. In addition,
the surgeon restores valve function and cardiac integrity.
Surgery is, however, always followed by a full course of
intravenous antimicrobial therapy for cure.
PVE is generally more invasive than NVE and more
difficult to cure with antibiotics alone. Biofilm formation
represents a biological basis for the more frequent need
for surgery in PVE. Comparing aortic to mitral valve IE,
aortic valve IE is more often invasive (both aortic NVE and
PVE) (10). Despite this, outcomes are worse after surgical
treatment of mitral valve IE than aortic valve IE (10). Three
important factors contribute to this: (I) mitral valve IE
patients are sicker with more comorbidities; (II) for invasive
IE, the surgical anatomy of mitral valve IE is less favorable;
and (III) no allograft valve alternative for severe invasive
disease currently exists for the mitral valve. Right-sided IE
typically is less invasive, although it is more often caused by
aggressive organisms, including S aureus, than left-sided IE.
In the following segment, the specific recommendations
are reviewed as per Figures and themes in the guideline
document (1).
AATS guidelines themes and questions
Team approach for patients with IE (Figure 1)
(2-4,6,8,18,19)
Patients with suspected IE should ideally be referred
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early to centers with access to a complete team, including
cardiology, infectious disease, cardiac surgery, and services
needed to handle IE-related complications (e.g., neurology,
psychiatry, and nephrology). Surgical input should be
solicited early in the evaluation. Surgeons operating on
patients with IE need to be well-trained, experienced
valve surgeons well versed in the different reconstruction
techniques needed by patients with advanced disease.
Diagnosis of IE and essentials for surgical planning
(Figure 1)
Diagnosis of IE is based on clinical symptoms, physical
findings, microbiology results, echocardiography, and
other studies. Duke or modified Duke criteria are used to
classify certainty of the diagnosis (14,15). A transthoracic
echocardiogram (TTE) must be supplemented with
TEE in most cases of suspected prosthetic IE. A TEE
should be considered early when organisms with a high
likelihood of pyogenic complications are implicated or
when there is a question about the presence or absence of
valve infection based on the quality of the TTE images.
Use of imaging modalities other than echocardiography
may be appropriate in selected cases. Electrocardiogramgated CT has comparable diagnostic performance to TEE
and may be a valuable complement in the preoperative
evaluation of patients with aortic PVE. Multidetector CT
(MDCT) can be used to detect abscesses/pseudoaneurysms
with a diagnostic accuracy similar to TEE, and is possibly
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superior in providing information about the extent of
any perivalvular extension, including the anatomy of
pseudoaneurysms, abscesses, and fistulas. Other diagnostic
modalities like single-photon emission computed
tomography (SPECT)-CT imaging with radiolabeled
leukocytes and 18F-fluorodeoxyglucose (FDG) PET-CT
imaging can be useful in securing the diagnosis, and in
detection of peripheral embolic and metastatic infectious
events.
When going to the operating room, the patient should
be on an effective antimicrobial regimen when organism
and sensitivity are known, or be broadly covered when these
unknown.
For surgical planning, it is imperative for the surgeon
to carefully review the echocardiograms and other imaging
studies to better understand the pathology and stage of the
disease for appropriate surgical planning. However, it is
important to remember that even TEE is not necessarily
perfectly accurate, particularly in patients with mechanical
valves.
Indications for and timing of surgery for patients with
IE (Figure 2) (2-6,10-13,20-32)
The AATS recommendations, although similar, are not
identical to the ACC/AHA recommendations (2,4). Minor
changes and nuances have been added. Surgical treatment
should be considered in patients with signs of heart failure,
severe valve dysfunction, prosthetic PVE, invasion with
paravalvular abscess or cardiac fistulas, recurrent systemic
embolization, large mobile vegetations, and persistent sepsis
despite adequate antibiotic therapy for more than 5 to
7 days. Factors related to complications, primarily
neurologic and comorbidities, must be considered and
weighed in the decision-making process (2,4). The AATS
guidelines emphasize that reason and timing of surgery
cannot be separated but must be seen in relation to each
other. The final decision to operate should be a consensus
decision by the treating team.
The main disagreement relates to the level of
aggressiveness and definition of early surgery.
Approximately half of patients with IE develop severe
complications that sooner or later require operation. The
AATS guidelines conclude that once a surgical indication
is evident, surgery should not be delayed. In patients with
NVE, waiting for heart failure symptoms in a patient
with severe valve regurgitation and vegetations does not
offer any benefit. Studies by Kang et al. and by many
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other experienced groups recommend operating before
heart failure has developed (13). In Kang’s study, the most
frequent complication in the conventional treatment group
was embolic stroke.
Patients with invasive staphylococcal PVE and early
PVE require early surgery. Delaying surgery allows the
destruction to progress and increases the risk of heart block
and embolism. For patients with uncomplicated, nonstaphylococcal, and late PVE, treatment with antibiotics
alone may be worth trying, but often the infection recurs
within a few months.
Surgery during initial hospitalization before completion
of a full therapeutic course of antibiotics is indicated in
patients with IE who present with valve dysfunction and
heart failure symptoms, patients with left-sided IE caused by
S. aureus, fungal or other highly resistant microorganisms,
or patients with evidence of persistent infection as
manifested by persistent bacteremia or fever lasting longer
than 5 to 7 days after initiation of appropriate antimicrobial
therapy (1-5).
AATS guidelines recommend urgent or even emergency
surgery in patients with left-sided NVE or PVE who
exhibit mobile vegetations greater than 10 mm in length
with clinical evidence of embolic phenomenon despite
appropriate antibiotic therapy. Large mobile vegetations—
greater than 10 mm on the anterior mitral valve leaflet—
have been proven to be associated with higher embolic
risk (8,13). Location, size, and mobility of the vegetation,
previous embolism, type of organism, and duration of
antimicrobial therapy all influence the associated risk of
another embolic event. The trend is to be more aggressive
and operate on patients at imminent risk of embolism
earlier. The additional risk of operating on patients with
active IE is low and when the indication is large vegetations
and risk of embolism, it is frequently possible to preserve
the valve, more often so for the mitral than the aortic valve.
A recurrent embolic event may occur at any point and may
be devastating.
The general indications discussed above may or may
not be applicable to right-sided IE. When multiple valves,
left- and right-sided, are infected, the indication for surgery
is usually decided by the left-sided IE. In right-sided IE,
indications for surgery are most often failure to control the
infection and septic pulmonary embolism, and less often
tricuspid valve regurgitation in itself. One consequence
of pulmonary embolism is increasing pulmonary vascular
resistance and reduced ability to tolerate valve regurgitation,
resulting in congestion and right-heart failure symptoms.
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Recommendations

COR

LOE

Surgery during initial hospitalization independently of the completion of a full therapeutic course of antibiotics is
indicated in patients with IE who present with valve dysfunction resulting in symptoms of heart failure

I

B

Surgery during initial hospitalization independently of the completion of a full therapeutic course of antibiotics is
indicated in patients with left-sided IE caused by S. aureus, fungal, or other highly resistant microorganisms

I

B

Surgery during initial hospitalization independently of completion of a full therapeutic course of antibiotics is indicated
in patients with IE complicated by heart block, anular or aortic abscess, or destructive penetrating lesions

I

B

Surgery during initial hospitalization independently of completion of a full therapeutic course of antibiotics for IE is
indicated in patients with evidence of persistent infection as manifested by persistent bacteremia or fever lasting longer
than 5 to 7 days after initiation of appropriate antimicrobial therapy

I

B

Surgery is recommended for patients with PVE and relapsing infection (defined as recurrence of bacteremia after a
complete course of appropriate antibiotics and subsequently negative blood cultures) without other identifiable source
for portal of infection

IIa

C

Surgery during initial hospitalization independently of the completion of a full therapeutic course of antibiotics is
reasonable in patients with IE who present with recurrent emboli and persistent vegetations despite appropriate
antibiotic therapy

IIa

B

Urgent or even emergency surgery may be considered in patients with NVE or PVE who exhibit mobile vegetations
greater than 10 mm in length with clinical evidence of embolic phenomena despite appropriate antimicrobial treatment

IIb

B

In patients with right-sided IE, surgery should be considered for NVE or PVE when large vegetations are present and
there is evidence of persistent infection manifested by persistent bacteremia or fevers lasting longer than 5 to 7 days
after initiation of appropriate antimicrobial therapy, or in those with evidence of septic pulmonary embolism

IIb

B

I

B

Earlier surgery (emergency or within 48 hours) is reasonable for patients with large mobile vegetations at imminent risk
of embolism

IIa

B

In patients with stroke and neurologic deficits, timing is decided by weighing the need for cardiac surgery against
the risk of expanding the stroke or provoking intracranial bleeding during the operation (see specific question about
neurologic complications)

IIa

B

1. What are the indications for surgery in patients with IE?

2. When should the patient undergo operation?
Once an indication for surgery is established, the patient should be operated on within days

Figure 2 Indications for and timing of surgery for patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST, et al. 2016
American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac Cardiovasc
Surg 2017;153:1241-1258.e29, with permission from Elsevier.

As per the AATS guidelines, in patients with right-sided
IE, surgery should be considered for NVE or PVE when
large vegetations are present (large for right side defined as
>20 mm) and the patient has persistent bacteremia or fevers
lasting longer than 5 to 7 days after initiation of appropriate
antimicrobial therapy, or in those with evidence of septic
pulmonary embolism (3,6,18,19).
Early surgery is defined as surgery “during initial
hospitalization independent of completion of a full
therapeutic course of antibiotics.” (2,4). Surgery undertaken
for the prevention of embolism is mainly relevant early,
during the first few days after initiating antimicrobial
therapy (emergency or urgent). Risk of embolism is highest
during the first two weeks of antibiotic therapy and is
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clearly related to size and mobility of the vegetations,
although other risk factors exist. The risk of stroke in
IE falls dramatically each day after initiation of effective
antimicrobial therapy. Reduction in size of vegetations
with appropriate antimicrobial therapy also appears to be
associated with reduced embolic risk.
As per the AATS guidelines, once an indication for
surgery is established, the patient should be operated on
within days, and earlier surgery (emergency or within
48 hours) is reasonable for patients with large mobile
vegetations at imminent risk of embolism (2-5,12,21,33,34).
In patients with stroke and neurologic deficits, timing is
decided by weighing the need for cardiac surgery against
the risk of expanding the stroke or provoking intracranial
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Recommendations

COR

LOE

1. What is the effect of neurologic complications, embolic stroke, brain hemorrhage, and mycotic aneurysm on indication for and timing
of surgery?
If a cerebral mycotic aneurysm has been diagnosed, treatment and follow-up of the patient should be in close collaboration
with neurologic and neurosurgery expertise

I

C

In patients with a recent intracranial hemorrhage, a delay of operation for 3 or more weeks is reasonable

IIa

B

Earlier surgery is reasonable for patients with non-hemorrhagic strokes and a strong cardiac indication for urgent surgery

IIa

B

Patients with large and multiple strokes and severe neurologic symptoms should be carefully evaluated by a neurologist
before being offered surgery

I

B

IIa

B

I

B

IIa

B

For patients with IE and neurologic symptoms and significant intracranial hemorrhage, angiography should be considered to
rule out mycotic aneurysm
2. Should all IE patients scheduled for surgery have preoperative brain imaging?
Endocarditis patients with neurologic symptoms should have brain imaging
It is reasonable to screen patients with left-sided IE for possible stroke or intracranial bleeding before operation, particularly
if they have cardiac lesions considered high risk for embolic events

3. What workup is needed for diagnosing primary infectious focus, secondary manifestations and complications (other than neurologic),
and satellite infections in patients with IE?
Patients with IE should be screened for primary non-cardiac focus of infection, non-cardiac complications, and satellite
infections: The choice of diagnostic procedure (e.g., CT, MRI, ultrasonography) varies, and the selection should be
individualized for each patient based on clinical symptoms and suspicions

I

C

Anticoagulation management in patients who have compelling indications for anticoagulation, e.g., atrial fibrillation,
mechanical prosthetic valve, deep vein thrombosis, or pulmonary embolism, has to seek compromises, taking all risks and
benefits into consideration

I

C

Heparin should be used cautiously in all patients with IE, particularly when there is evidence of brain hemorrhage, and be
temporarily withheld in patients with higher risk of rebleed

I

B

4. How should anticoagulation in patients with IE, with and without stroke or intracranial bleeding, be managed?

Figure 3 Pre-surgical work-up and management of patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST, et al. 2016
American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac Cardiovasc
Surg 2017;153:1241-1258.e29, with permission from Elsevier.

bleeding during the operation (2-5,20-27,31-36).
Presurgical work-up and management of patients with
IE (Figure 3)
Neurologic complications and role of brain imaging in
patients with IE (2-4,20-24,33-40)
IE patients with neurologic symptoms scheduled for surgery
should have a neurologic evaluation by a neurologist,
and brain imaging, either by CT or MRI, within days
of the planned operation to visualize any strokes and
to determine if an infarct is ischemic or hemorrhagic.
Routine preoperative screening of asymptomatic patients,
particularly those with high-risk vegetations, is justified.
The neurologic symptoms, consciousness, location and
size of infarct, type (primary or hemorrhagic conversion
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in infarct), location, size, and timing of hemorrhage, and
risk and probability of mycotic aneurysm are all factors
to consider when deciding on further imaging, operative
risk, and timing of surgery. The standard recommendation
is to delay surgery for 1 to 2 weeks in patients with nonhemorrhagic strokes, and for 3 to 4 weeks in patients
with hemorrhagic strokes to reduce the risk of further
intracranial bleeding during heart surgery. Patients
with serious neurologic damage, unconscious patients,
and those unable to follow simple commands should
not be operated on until neurologic improvement has
been demonstrated and potential for recovery has been
established. Hemorrhagic lesions are associated with a
higher probability of mycotic aneurysms, and these patients
need to undergo cerebral angiography to exclude a mycotic
aneurysm. Presence of a mycotic aneurysm increases the
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risk of peri- and postoperative bleeding, and the neurologist
and neurosurgeon should decide whether to treat and
secure the aneurysm before the heart operation.
For those with non-hemorrhagic embolic strokes, the
main concerns are worsening the neurologic damage due
to hemorrhagic conversion of the infarct and edema during
the operation. The risk of worsening neurologic symptoms
as a consequence of operation is time related, decreasing
with increasing time from the initial neurologic event. If the
patient is stable and risk of additional embolism is deemed
to be low, delaying surgery for 1 to 2 weeks is probably
beneficial, with repeat brain imaging before operation. The
risk of worsening the stroke symptoms must be weighed
against the indications for surgery and the risk of additional
emboli during the waiting period.
Given the high rate of brain embolization detected in
patients without clinical neurologic deficits, patients with
left-sided IE should be screened by CT or MRI for possible
stroke or intracranial bleeding.

consideration.
There are many scenarios in which compromises are
preferable, i.e., less anticoagulation rather than more
seems safer. If the patient has suffered a stroke, any
anticoagulation adds to the risk of hemorrhagic conversion,
and if bleeding has already occurred, this risk increases
even more. Managing a patient with an infected rocking
mechanical valve and intracranial bleeding remains a
difficult dilemma.

Screening for primary infectious focus, non-neurologic
complications, and satellite infections in patients with IE
(Figure 3)
Symptoms, specific signs, and causative organism should
guide the search for other sources of bacteremia, satellite
infections (brain, spine, or splenic abscesses in left-sided
IE, pulmonary abscess in right-sided IE) and mycotic
aneurysms. The choice of diagnostic modality or procedure
(e.g., CT, MRI, ultrasonography) varies, and the selection
should be individualized for each patient based on clinical
symptoms and suspicions. Imaging with CT or MRI of the
chest and abdomen may be justified in select cases, e.g.,
patients with Aspergillus IE. As per the AATS guidelines, if
patients with IE are diagnosed with another infectious focus
or abscess (spinal, splenic, or other), the treatment team has
to take this finding into consideration and decide timing of
intervention for this versus timing of valve surgery.
Anticoagulation in patients with IE, with and without
stroke or intracranial bleeding (Figures 2,3)
Not only is anticoagulation ineffective in preventing septic
emboli, being on anticoagulation also increases the risk of
hemorrhagic conversion of an ischemic stroke and brain
hemorrhage. Anticoagulation management in patients with
IE who have compelling indications for anticoagulation,
e.g., atrial fibrillation, mechanical prosthetic valve,
deep vein thrombosis, or pulmonary embolism, must
seek compromises, taking all risks and benefits into

© Annals of Cardiothoracic Surgery. All rights reserved.

Additional workup needed just before taking the
patient to surgery (Figure 4)
When the decision has been made to operate on a patient
with IE, repeat brain imaging may be needed, depending on
new neurologic symptoms, time since the last examination,
risk of embolism based on organism, vegetations,
and pathology, and whether previous brain imaging
demonstrated a stroke or hemorrhage.
Indications for coronary angiography should follow
normal criteria for other surgical conditions, particularly
if the patient has had coronary artery bypass grafting. In
patients with large aortic vegetations, CT angiography is an
alternative to assess the coronary arteries.
When repeat sternotomy is required, a preoperative CT
of the chest is required to assess the risk of sternal entry.
For this purpose, MRI does not provide equally precise
information. Contrast is not needed unless there are grafts
to be localized as well.
Preoperative duration of antibiotic treatment
The patient should be on an effective antimicrobial
regimen at the time of surgery. The probability of positive
cultures from an explanted valve decreases with duration of
preoperative treatment and reaches its lowest level after 1
week, with no further improvement. There is no evidence
that delaying the surgery to allow a longer period of
preoperative treatment is beneficial.
General features of intraoperative management of
patients with IE (Figure 5)
Intraoperative TEE
Intraoperative comprehensive TEE should be routine
because there may be an interval from initial diagnostic
imaging to surgery. Upon completion of the operation,
another comprehensive echocardiogram should be
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Recommendations

COR

LOE

IIa

B

I

C

IIa

C

I

B

IIa

B

I

C

1. What additional workup is needed just before taking the patient to surgery?
When surgery is decided upon, before going to the operating room, it is reasonable to obtain brain imaging or repeat brain
imaging
The need for preoperative coronary angiography should be guided by normal criteria. This is particularly important if the
patient has had coronary artery bypass grafting. In patients with large aortic valve vegetations, CT angiography is an
alternative to assess the coronary arteries
When repeat sternotomy is required, computed tomography of the chest is recommended when possible to assess risk of
sternal reentry
2. Is preoperative duration of antibiotic treatment important?
The patient should be on an effective antimicrobial regimen at the time of surgery. Ideally, the sensitivity of the causative
organism is known
Once the patient is on an effective antimicrobial regimen, further delay of surgery is unlikely to be beneficial
3. What is the risk of operation for IE?
The patient should be quoted a risk, taking into consideration all factors known to affect the risk of the operation

Figure 4 Additional work-up, preoperative antibiotics, and risk of operation for patients with IE. Reproduced from Pettersson GB, Coselli
JS, Hussain ST, et al. 2016 American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective
Endocarditis. J Thorac Cardiovasc Surg 2017;153:1241-1258.e29, with permission from Elsevier.

performed to detect any important residual pathology or
complications, and should be recorded.
Operative approach
Sternotomy is required for most patients undergoing IE
operations, because unexpected findings and discovery of
more advanced disease than anticipated are common. Good
exposure is required for radical debridement. If unsuspected
invasive disease is present, alternate minimally invasive
approaches are likely to provide insufficient exposure.
Radical debridement
All infected material, foreign bodies, and necrotic tissue
should be removed to minimize the residual infectious
burden and provide optimal access for host defense and
antimicrobial therapy. “Radical” does not with wide
margins, which may jeopardize valve repair, injure
coronaries, cause permanent heart block, and make
reconstruction of the heart more difficult. Infected areas are
opened and “unroofed”, and all infected pockets cleaned
out. In patients with PVE, debridement should include
removal of the old prosthesis and suture material. In
patients with mitral anular calcification, debridement must
remove infected calcium but removal must not be so radical
that reconstruction is jeopardized. Debridement is followed
by generous irrigation. Surgical instruments and gloves
should be exchanged after removing all infected tissue and
© Annals of Cardiothoracic Surgery. All rights reserved.

completing irrigation.
General considerations and recommendations for choice of
reconstruction and valve replacement (Figures 5,6) (41-49)
For NVE, and for the mitral valve in particular, valve repair
over replacement is preferred whenever possible (41,42).
When simple valve replacement is required, choice of
valve—mechanical or tissue prosthesis—should be based
on normal criteria: age, life expectancy, comorbidities, and
expected compliance with anticoagulation. For patients
with invasive disease and destruction, reconstruction should
depend on the involved valve, severity of destruction, and
available options for cardiac reconstruction
Several studies have suggested that use of an allograft
in patients with aortic valve IE is associated with better
survival and lower risk of relapse (no early phase of
recurrent infection) (43-46). Due to technical difficulty and
lack of evidence of superior resistance to reinfection, many
surgeons prefer other conduits for reconstruction (44).
However, allografts are still used more often in invasive
PVE cases (47). In patients who are very sick, have had any
intracranial bleeding, or have suffered a major stroke, it is
reasonable to avoid use of mechanical prostheses. Using
allografts or bioprosthetic valves avoids postoperative
anticoagulation, and lowers the risk of hemorrhagic
conversion of strokes and other bleeding complications in
these patients.
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Recommendations

COR

LOE

I

B

I

C

I

B

For patients with NVE and infection limited to the valve cusps or leaflets, repair is performed whenever possible

I

B

When simple valve replacement is required, choice of valve—mechanical or tissue prosthesis—should be based on normal criteria: age,
life expectancy, comorbidities, and expected compliance with anticoagulation

I

B

It is reasonable to avoid use of mechanical prostheses in patients with any intracranial bleeding or those who have suffered a major stroke

IIa

C

I

B

I

B

IIa

B

If the root and the anulus are preserved after radical debridement, it is reasonable to implant a new prosthetic valve—mechanical or
tissue—based on normal criteria

IIa

B

If there is anulus destruction and invasion outside the aortic root and root reconstruction and replacement is required, an allograft or a
biologic tissue root is preferable to a prosthetic valved conduit

IIa

B

1. Intraoperative TEE
Intraoperative TEE is mandatory when performing surgery for IE
2. Operative approach
Medium sternotomy is the recommended approach, with few exceptions
3. Removal of infected tissue: Radical debridement
All infected and necrotic tissue and foreign material should be radically debrided and removed
4. Choice of reconstruction and valve replacement: General considerations and recommendations

For patients with invasive disease and destruction, reconstruction should depend on the involved valve, severity of destruction, and
available options for cardiac reconstruction
5. Native aortic valve IE
For patients with native aortic valve IE and infection limited to the valve cusps, repair may occasionally be possible. Choice of
replacement valve—mechanical or tissue prosthesis—should be based on usual criteria
For invasive and destructive native aortic valve IE requiring root reconstruction and replacement, using an allograft may be beneficial,
but a prosthetic bioroot or prosthetic valved conduit with a mechanical or bioprosthetic valve are acceptable alternatives, with choice
guided by surgeon training and experience
6. Prosthetic aortic valve IE

7. Native mitral valve IE
Mitral valve repair is the preferred choice whenever possible, including use of a prosthetic annuloplasty ring when appropriate

I

B

When valve replacement is required, a prosthetic valve, either mechanical or tissue, is acceptable, unless there is risk of intracranial
bleeding, in which case a tissue valve is preferred

IIa

B

When there is anulus destruction and invasion, the mitral anulus is reconstructed and the valve prosthesis anchored to the ventricular
muscle or to the reconstruction patch in a way that prevents leakage and pseudoaneurysm development beneath the prosthesis

IIa

B

A new prosthetic mitral valve, mechanical or tissue, is acceptable, unless there is risk of intracranial bleeding, in which case a tissue
valve is preferred

IIa

B

When there is anulus destruction and invasion, the mitral anulus is reconstructed and the valve prosthesis anchored to the ventricular
muscle or to the reconstruction patch in a way that prevents leakage and pseudoaneurysm development beneath the prosthesis

IIa

B

If the aortic root and aortic and mitral anuli are preserved after radical debridement, it is reasonable to implant mechanical or biologic
valves, with the choice based on normal criteria

IIa

B

If there is aortic anulus destruction and invasion, and root reconstruction and replacement is required, an allograft or bioroot may be
preferable to a prosthetic valved conduit, and if the mitral anulus shows invasion and destruction, it should be reconstructed to anchor
the valve prosthesis to the ventricular muscle or to the anulus reconstruction patch to avoid leakage and pseudoaneurysm development
beneath the prosthesis

IIa

B

Infection destroying the intervalvular fibrosa requires reconstruction of this structure, and it is preferable that surgeons taking on these
cases master such techniques

IIa

C

The primary objective of surgery for right-sided IE is radical debridement of infected vegetations and foreign material

I

B

Tricuspid valve repair should be attempted whenever possible

I

B

8. Prosthetic mitral valve IE

9. Double-valve IE

10. Right-sided IE

Figure 5 General features of intraoperative management of patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST, et
al. 2016 American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac
Cardiovasc Surg 2017;153:1241-1258.e29, with permission from Elsevier.
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COR

LOE

1. Should regular synthetic vascular grafts or valveless allografts be used when the aorta must be replaced beyond the root?
When distal ascending aorta, hemiarch, or arch replacement is required, a synthetic graft is the standard choice, but a
valveless allograft is an alternative in an infected field for replacing the ascending aorta beyond the root

IIb

B

IIa

C

I

B

Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is reasonable in patients with
right- or left-sided valvular IE caused by S. aureus or fungi, even without evidence of device or lead infection

IIa

B

Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is reasonable in patients
undergoing surgery for valvular IE caused by any organism

IIb

C

2. Should additional prostheses and vascular grafts not proved to be infected be removed and replaced?
Inspection and removal of additional prostheses and vascular grafts, even if not proven to be infected, should be considered
and is reasonable if the causative microorganism is S. aureus or fungus, provided that the added difficulty and risk is not
prohibitive
3. When should permanent pacemaker systems be removed in patients undergoing surgery for IE?
Complete removal of pacemaker or defibrillator systems, including all leads and the generator, is indicated as part of the
early management plan in patients with IE and likely infection of the device or leads

4. Should patients with a known indication for a pacemaker receive a pacemaker system with epicardial leads when undergoing
operation for active IE?
At the time of surgery for IE, implantation of a new pacemaker system with epicardial leads may be considered when the
patient is pacer dependent and has effective antimicrobial coverage

IIb

C

I

C

I

C

IIb

C

Operative specimens should be secured for examination by the pathologist to determine presence of organisms and
inflammatory activity

I

B

Operative specimens should be used for microbiologic and molecular testing to identify or confirm the pathogens and their
sensitivity to antimicrobial therapy

I

A

IIa

B

I

B

After surgery for active IE, standard duration of postoperative intravenous antimicrobial treatment is 6 weeks, counted from
the day of surgery, but regimen and duration may be modified and adjusted depending on the organism and its sensitivity to
antimicrobials, treatment response, and pathology

IIa

B

For fungal IE, lifelong oral suppressive therapy is reasonable

IIa

B

5. Are there any safety concerns regarding use of mechanical valves in patients with IE?
Mechanical valves should be avoided in patients with IE and evidence of intracranial bleeding or large brain infarcts, and in
patients who are very sick and anticipated to have a prolonged postoperative course
6. Is there any role for local antimicrobials or antiseptics during surgery for IE?
After completed debridement, generous irrigation of the surgical field with normal saline is recommended
7. How should infected areas be drained?
Whenever feasible, leaving infected areas open to the circulation or the pericardium is optimal from the standpoint of
treating the infection
8. How should operative specimens be handled?

9. What is the role of molecular testing with PCR in identifying pathogens?
Whenever there is clinical suspicion of IE and doubt about the causative organism, molecular testing can be useful to
identify and confirm the pathogens or causative organisms in the operative specimens
10. What postoperative antimicrobial treatment is required, and for how long should the patient be treated?
When perioperative cultures and organism sensitivity are known, the antimicrobial regimen and duration of treatment are
reconsidered and decided upon

Figure 6 Specific considerations in surgical management of patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST,
et al. 2016 American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac
Cardiovasc Surg 2017;153:1241-1258.e29, with permission from Elsevier.
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For native aortic valve IE, repair is only occasionally
possible. When the disease is invasive reconstruction and
root replacement are usually required. Prosthetic valve
infections often involve the sewing ring circumferentially.
Occasionally the sewing ring is infected, but the infection has
not yet penetrated deeper and outside the root. When that
is the case and the debridement is adequate, it is possible
and feasible to implant another prosthetic valve of choice.
However, deeper invasion and destruction of the annulus
is more common with aortic PVE. Allograft is certainly the
Cleveland Clinic preferred conduit in patients with more
extensive and destructive infection.
Fortunately, invasive and destructive disease is less
common with mitral than aortic valve IE, and when
invasion occurs it is more often shallow. Mitral valve
repair is performed whenever possible and a prosthetic
annuloplasty ring is added whenever appropriate. When
valve replacement is required, a prosthetic valve, either
mechanical or tissue, is acceptable, unless there is risk
of intracranial bleeding, in which case a tissue valve is
preferred. When, however, mitral valve invasion penetrates
deeper into the atrioventricular groove, it is much
more serious, and radical debridement and sterilization
and drainage of the infected area are more difficult. In
patients with mitral PVE, the exposure for debridement
and removal of the old prosthesis and suture material is
worse than for the aortic valve and left ventricular outflow
tract. Fortunately, deep invasion into the atrioventricular
groove is uncommon, allowing direct implantation of a
new prosthesis without additional reconstruction in most
cases. When anulus reconstruction is needed, autologous
pericardium, bovine pericardium, and other materials can be
used. Repair patches must be generous to minimize tension
on the suture lines and the valve prosthesis anchored to the
ventricular muscle or to the reconstruction patch in a way
that prevents leakage and pseudoaneurysm development
beneath the prosthesis.
The primary objective of surgery for right-sided IE is
most often to eliminate the cause of persistent sepsis and the
source of septic emboli to the lung, by radical debridement
of infected vegetations and foreign material. Tricuspid
valve repair should be attempted whenever possible (50-52).
Any prosthetic valve in the tricuspid position is associated
with increased risk of recurrent IE, particularly in patients
who resume intravenous drug use. Bioprosthetic valves
are preferred, although this preference is not based on any
comparative studies. With mechanical valves there may
be an increased risk of thrombosis and access to the right

ventricle and pulmonary artery for catheterization and
pacemaker leads is lost.
When distal ascending aorta, hemiarch, or arch
replacement is required, a synthetic graft is the standard
choice, but a valveless allograft is an alternative in an
infected field for replacing the ascending aorta beyond
the root. Extending an allograft into the arch may set up a
more difficult reoperation if the allograft has had time to
calcify. In reoperative surgery, inspection and removal of
additional prostheses and vascular grafts, even if not proven
to be infected, should be considered and is reasonable if the
causative microorganism is S. aureus or fungus, provided
that the added difficulty and risk is not prohibitive. If it is
easy and associated with limited added risk, those implants/
vascular grafts are replaced, whereas if it is difficult and adds
to operative risk significantly, they are left alone (53).

© Annals of Cardiothoracic Surgery. All rights reserved.

Patient with IE and permanent pacemaker systems in place
(Figure 5) (2,3,54,55)
Complete removal of pacemaker or defibrillator systems,
including all leads and the generator, is indicated as part
of the early management plan in patients with IE and
likely infection of the device or leads. In patients with
right- or left-sided valvular IE caused by S. aureus or fungi,
complete removal of pacemaker or defibrillator systems
is recommended; even without evidence of device or lead
infection.
In patients undergoing surgery for IE, removal of leads
adds to complexity postoperatively and raises questions if,
when, and how the system should be replaced. At the time
of surgery for IE, implantation of a new pacemaker system
with epicardial leads is a good option when the patient is
pacing-dependent and has effective antimicrobial coverage.
Placing epicardial leads at the time of surgery is even
more attractive in patients at increased risk of becoming
reinfected, e.g., those on dialysis, intravenous drug users,
or those with ongoing bacteremia at the time of pacemaker
removal. However, epicardial leads are not quite as reliable
and pacing thresholds are often higher, causing more rapid
draining of the pacemaker power supply. A discussion with
an electrophysiologist preoperatively may be warranted.
Other considerations in surgical management of patients
with IE (Figure 6)
The AATS emphasize that specimens should be
handled properly and divided between pathology and
microbiology for microscopy and cultures. Molecular
testing with Polymerase Chain Reaction (PCR) should be

Ann Cardiothorac Surg 2019;8(6):630-644 | http://dx.doi.org/10.21037/acs.2019.10.05

Annals of cardiothoracic surgery, Vol 8, No 6 November 2019

641

Recommendations

COR

LOE

Primary infectious focus and microorganism portal of entry must be treated during or just after the IE episode, including
follow-up and screening for underlying infectious foci and morbidities

I

B

IE caused by Streptococcus gallolyticus is an indication for colonoscopy within a reasonable time after operation

I

B

Patients with a history of injection drug use should be treated for their addiction

I

B

After surgery for IE, eradication of the pathogen is essential and should be verified by follow-up for 6 months with an
infectious disease specialist

I

C

After valve surgery for IE, cure of the infection should be documented by echocardiogram, and the patient should follow up
with a cardiologist

I

C

I

B

IIa

C

Normal indications for surgery are also reasonable to apply to patients on dialysis, but their additional comorbidity must be
factored into their risk and outcome assessment

IIa

C

Patients with renal failure have shorter durability of bioprostheses and allografts because of early calcification, and this may
be considered in the choice of an allograft or a bioprosthesis versus a mechanical valve

IIa

B

IIa

C

IIb

B

I

C

1. What is the need for follow-up and additional screening for infectious foci that could cause recurrent infection/IE?

2. What is the risk of relapse and recurrent IE?
Patients who have undergone surgery for IE should be informed about the increased risk of recurrent IE and the need for
prophylaxis
3. Should surgical treatment be offered to injection drug users with IE?
Normal indications for surgery are reasonable to apply to patients who are intravenous drug users. Decision-making must
take the addiction into account, and management must include treatment of the addiction
4. Should surgical treatment be offered to IE patients on dialysis?

5. Should surgical treatment be offered to IE patients with liver cirrhosis?
Normal indications for surgery are reasonable to apply to patients with liver cirrhosis, but their additional comorbidity must
be factored into their risk and outcome assessment
6. Who should get antibiotic prophylaxis for IE?
Patients who have undergone surgery for IE constitute a high-risk group for recurrent IE and should be recommended for IE
prophylaxis according to guidelines
7. How should patients with remote IE be managed?
Normal indications for valve repair or replacement apply to patients with healed or remote IE, but conditions predisposing
for IE should be diagnosed and treated

Figure 7 Surveillance and special considerations for patients with IE. Reproduced from Pettersson GB, Coselli JS, Hussain ST, et al. 2016
American Association for Thoracic Surgery (AATS) Consensus Guidelines: Surgical Treatment of Infective Endocarditis. J Thorac Cardiovasc
Surg 2017;153:1241-1258.e29, with permission from Elsevier.

considered whenever there is uncertainty regarding the
causative microorganism. PCR may identify the causative
microorganism in many cases of IE where blood and valve
cultures have failed (56-58).
After surgery for active IE, standard duration of
postoperative intravenous antimicrobial treatment is
6 weeks, counted from the day of surgery, but regimen and
duration may be modified and adjusted depending on the
organism and its sensitivity to antimicrobials, treatment
response, and pathology. For fungal IE, lifelong oral
suppressive therapy is reasonable and used more often.

© Annals of Cardiothoracic Surgery. All rights reserved.

Long-term, even life-long suppression has also been used
in patients with infected vascular grafts and other implant
infections. The efficacy of long term suppression has not
been well studied.
Other special considerations for patients with IE (Figure 7)
The number of patients presenting with IE who are
intravenous drug users has increased tremendously over the
last decade. Drug addicted patients are younger and have
lower surgical risk; the main issue is high risk of relapse and
recurrent IE (18). They present with two deadly conditions,
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the IE and the addiction. The guidelines recommend
that normal indications for surgery are applied to patients
who are intravenous drug users but management must
include treatment of the addiction. Access to treatment for
addiction is very difficult because of a lack of providers and
facilities, and lack of insurance and other means to pay for
the scarce resources that may be available
The operative risk for patients on dialysis is higher and
long-term outcomes are worse than for patients who are
not on dialysis (59,60). Nevertheless, the guidelines still
recommend application of normal indications for surgery.
Patients with renal failure have shorter durability of
bioprostheses and allografts because of early calcification,
and this may be considered in the choice of an allograft or a
bioprosthesis versus a mechanical valve.
Similarly, in patients with liver cirrhosis, additional
comorbidity must be evaluated and factored into their risk
and outcome assessment but otherwise normal indications
for surgery can be applied. The added operative risk
associated with liver cirrhosis is related to its severity, as
accessed by the Child-Pugh or Model for End-stage Liver
Disease (MELD) score.
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Antibiotic prophylaxis for IE
The AATS guidelines suggest that patients who have
undergone surgery for IE constitute a high-risk group
for recurrent IE and should be recommended for IE
prophylaxis accordingly.
Knowledge gaps
The most important knowledge gaps relate to timing of
surgery in patients with neurological complications, role of
early surgery to prevent embolism, and role of early surgical
intervention in those with PVE. These are all areas of
particular importance, requiring further research.
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